Table 3.
Qmax and PVR in tamsulosin, alfuzosin and silodosin at 1, 4 and 12 weeks
| Time | Parameter | Group T Mean ±SD | Group A Mean ±SD | Group S Mean ±SD | P value |
|---|---|---|---|---|---|
| 1 week | Vvol | 156.12 ±39.12 | 155.17 ±16.28 | 151.29 ±37.11 | 0.572 |
| Qmax | 11.90 ±2.95 | 13.11 ±2.63 | 13.76 ±2.44 | 0.028 | |
| PVR | 38.64 ±24.78 | 35.27 ±19.33 | 43.31 ±22.93 | 0.435 | |
| 4 weeks | Vvol | 153.21 ±31.11 | 159.19 ±43.12 | 154.13 ±23.18 | 0.440 |
| Qmax | 13.87 ±2.33 | 15.00 ±2.18 | 15.77 ±4.91 | 0.097 | |
| PVR | 27.96 ±17.36 | 30.18 ±17.24 | 29.25 ±17.86 | 0.910 | |
| 12 weeks | Vvol | 161.23 ±27.34 | 157.32 ±28.98 | 159.14 ±32.45 | 0.683 |
| Qmax | 14.33 ±2.15 | 15.76 ±2.08 | 16.15 ±4.81 | 0.083 | |
| PVR | 24.42 ±14.73 | 25.80 ±17.99 | 25.74 ±15.9 | 0.949 |
Vvol – voided volume (ml); Qmax – maximum flow rate (ml/second); PVR – post void residual urine (ml)